April 24, 2018 7:01 PM ET


Company Overview of DalCor Pharmaceuticals Canada Inc.

Company Overview

DalCor Pharmaceuticals Canada Inc. researches and develops precision medicine for patients suffering from cardiovascular diseases. The company was founded in 2015 and is headquartered in Montreal, Canada.

1010 Sherbrooke Street West

Suite 408

Montreal, QC H3A 2R7


Founded in 2015





Key Executives for DalCor Pharmaceuticals Canada Inc.

Chief Executive Officer
Age: 73
Compensation as of Fiscal Year 2017.

DalCor Pharmaceuticals Canada Inc. Key Developments

DalCor Pharmaceuticals Appoints Fouzia Laghrissi-Thode as Chief Executive Officer

DalCor Pharmaceuticals announced the appointment of Dr. Fouzia Laghrissi-Thode as Chief Executive Officer, effective April 3, 2018. Dr. Laghrissi-Thode is currently on the Board of Directors for DalCor. Dr. Laghrissi-Thode has more than 20 years of pharmaceutical industry leadership experience including leading the Dalcetrapib Dal-HEART program. Most recently, Dr. Laghrissi-Thode was Vice-President at AstraZeneca of the US Renal-Cardiology Therapeutic Area.

DalCor Announces Expansion and Accelerated Enrollment of the dal-GenE Clinical Trial

DalCor announced that the company will increase enrollment in its ongoing Phase 3 clinical trial of dalcetrapib from 5,000 to 6,000 patients. The decision for cohort expansion follows better than expected trial enrollment for dal-GenE, which has currently randomized a total of 4,300 patients, an estimated 5 months ahead of enrollment projections.

DalCor Pharmaceuticals Appoints Dr. Fouzia Laghrissi-Thode to the Board of Directors

DalCor Pharmaceuticals announced the appointment of Dr. Fouzia Laghrissi-Thode to its Board of Directors. Dr. Laghrissi-Thode is Vice-President at AstraZeneca. She has been leading the US Renal-Cardiology Therapeutic Area based in San Francisco and previously led the Global Cardiovascular Metabolism Therapeutic Area.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DalCor Pharmaceuticals Canada Inc., please visit dalcorpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.